ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Heart Test Laboratories Inc

Heart Test Laboratories Inc (HSCS)

5.38
0.07
(1.32%)
Closed June 16 4:00PM
5.25
-0.13
(-2.42%)
After Hours: 7:18PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.25
Bid
5.19
Ask
5.50
Volume
19,974
5.26 Day's Range 5.49
5.1001 52 Week Range 109.99
Market Cap
Previous Close
5.31
Open
5.48
Last Trade
1
@
5.46
Last Trade Time
Financial Volume
$ 107,858
VWAP
5.3999
Average Volume (3m)
2,138,242
Shares Outstanding
65,561,630
Dividend Yield
-
PE Ratio
-55.01
Earnings Per Share (EPS)
-0.1
Revenue
5k
Net Profit
-6.35M

About Heart Test Laboratories Inc

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. Show more

Sector
Ortho,prosth,surg Appl,suply
Industry
Ortho,prosth,surg Appl,suply
Headquarters
Southlake, Texas, USA
Founded
1970
Heart Test Laboratories Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker HSCS. The last closing price for Heart Test Laboratories was $5.31. Over the last year, Heart Test Laboratories shares have traded in a share price range of $ 5.1001 to $ 109.99.

Heart Test Laboratories currently has 65,561,630 shares outstanding. The market capitalization of Heart Test Laboratories is $349.44 million. Heart Test Laboratories has a price to earnings ratio (PE ratio) of -55.01.

HSCS Latest News

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Present at the LD Micro Invitational XIV Conference

Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences  (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Southlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Southlake, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.43-7.570422535215.685.95.22281655.54045137CS
4-3.45-39.65517241388.710.315.1001882686.07618912CS
12-6.75-56.251213.55.1001213824210.36671979CS
26-11.32-68.316234158116.5718.75.1001270068213.39593612CS
52-102.75-95.1388888889108109.995.1001330559118.02273464CS
156-369.75-98.63756005.1001215968779.10403916CS
260-369.75-98.63756005.1001215968779.10403916CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

HSCS Discussion

View Posts
tw0122 tw0122 2 weeks ago
It’s Gary G approved as long as NYSE Or Nasdaq get there fees from listing company who cares
👍️0
Awl416 Awl416 2 weeks ago
How is this trading legal?
👍️0
TheFinalCD TheFinalCD 1 month ago
HALTED Trading Halted for $HSCS Heart Test Laboratories Cmn | at 19:50:00 ET on NASDAQ | Halt - News Pending | 2024-05-16 https://t.co/MfA4lZm7jx #tradinghalt— LiquidityNews (@LiquidityNews) May 16, 2024
👍️0
The Night Stalker The Night Stalker 1 month ago
right
👍️0
INV4 INV4 2 months ago
Me too... (just a starter).

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

April 24, 2024

https://ih.advfn.com/stock-market/NASDAQ/heart-test-laboratories-HSCS/stock-news/93706569/heartsciences-announces-grant-of-fundamental-paten

$HSCS
👍️0
Triple nickle Triple nickle 2 months ago
Picked up quite a few more down here
👍️0
TheFinalCD TheFinalCD 3 months ago
34M S-1 https://ih.advfn.com/stock-market/NASDAQ/heart-test-laboratories-HSCS/stock-news/93429119/form-s-1-general-form-for-registration-of-securi
👍️0
Snoop_dog Snoop_dog 4 months ago
With all the heart issues. The UK 13% heart deaths vs 3% in a Year. This Co. Should be in the $10s
👍️0
Snoop_dog Snoop_dog 4 months ago
With all the heart issues. The UK 13% heart deaths vs 3% in a Year. This Co. Should be in the $10s
👍️0
Snoop_dog Snoop_dog 5 months ago
A lot of movement today get you bet's in before the big pump.
👍️0
Snoop_dog Snoop_dog 5 months ago
.10 to .02 around the corner but not after a nice pump and dump.
👍️0
Snoop_dog Snoop_dog 5 months ago
.10 to .02 around the corner but not after a nice pump and dump.
👍️0
Snoop_dog Snoop_dog 5 months ago
Pump and dump come
.90 it needs to get up to a $1 soon. Been under $1 for six months. Soon Nasdaq will kick them out. Look out people scam alerts.
👍️0
Snoop_dog Snoop_dog 5 months ago
All AI stock is up but this dog is a downgrade. SCAM ALERT CEO MIGHT BE STEALING .
👍️0
Snoop_dog Snoop_dog 5 months ago
This dog is a scam
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
chasing dilution is never fun..company is garbage and has no revenue....just massive dumping of toxic shares...chasers in ah say night night...chart is a disaster...dilute then split or delist
👍️0
Whalatane Whalatane 5 months ago
$HSCS Heart Test Laboratories has received a decision to grant European patent number EP3834729 titled "ELECTROCARDIOGRAM-BASED ASSESSMENT OF DIASTOLIC FUNCTION (USING MACHINE-LEARNED COMPUTATIONAL MODELS)". https://register.epo.org/application?number=EP20193719

Kiwi
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Gotcha! Good luck with a solid flip!
👍️0
TimeFades TimeFades 5 months ago
Flipperooni
👍️0
Invest-in-America Invest-in-America 5 months ago
O.K. THANKS!! (I grabbed some, then dumped for small loss; no big deal.)
👍️0
trendzone trendzone 5 months ago
If you have schwabs TD Ameritrade it's posted under their news, out at 15:59, it's there and it's still posted there.
👍️0
Invest-in-America Invest-in-America 5 months ago
Nope!!
👍️0
Invest-in-America Invest-in-America 5 months ago
WHERE??? Got a LINK???
👍️0
trendzone trendzone 5 months ago
It's posted as news after the close today,of granted European patent electronic cardiogram function using machine learned.
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Why are you loading? JC
👍️0
TimeFades TimeFades 5 months ago
Loading now
👍️0
TimeFades TimeFades 5 months ago
Yep
👍️0
Invest-in-America Invest-in-America 5 months ago
HSCS: Indeed!!! (I didn't post any iHub 'names' in here, because I think it was someone who inadvertently posted OLD news, thinking that it was TODAY, and guessed that such was the reason for its Post-M upwards price move. Bottom line, it is OVER!!)
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Jerks!
👍️0
Invest-in-America Invest-in-America 5 months ago
It's a SCAM!!! Or someone posted OLD "news" about their old Patents. (I had bought some after the Close today --- like a fool --- but dumped it all.)
👍️0
GeorgeTheStub GeorgeTheStub 5 months ago
20-minute after hours pump and dump...pretty strange timing on it though...
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Same for me. Must be a leak
👍️0
Invest-in-America Invest-in-America 5 months ago
HSCS: I myself could find NOTHING, but with only cursory "DD".
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Do you have a link to the news by chance?
👍️0
TimeFades TimeFades 5 months ago
Squeezy
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Ahhh ok! Beginnings of reversed pps trend?
👍️0
IVANj IVANj 5 months ago
Patent news
👍️0
threebabiesbusy threebabiesbusy 5 months ago
Why’s this moving up
👍️0
Deeznuts Deeznuts 6 months ago
Massive dilution by company
👍️0
TimeFades TimeFades 7 months ago
Looks like she’s about ready
👍️0
TimeFades TimeFades 7 months ago
Yawn , do or die by weeks end here imho
👍️0
1hot toddy 1hot toddy 7 months ago
they have a year. y would they even bring it up to vote. it will get voted down now. where do u see that they are thinking about it? i will vote noooooo
👍️0
1hot toddy 1hot toddy 7 months ago
i see it. im voting nooooooooooo now
👍️0
1hot toddy 1hot toddy 7 months ago
they have a year. y would they even bring it up to vote. it will get voted down now. where do u see that they are thinking about it? i will vote noooooo
👍️0
Sunset Kid Sunset Kid 7 months ago
News out... the anticipated r/s vote is on Jan 4th, unless we can get close to $1 by then, no record date set. They actually have until 11-22-24 to comply with min. share price I believe according to latest sec filing (8k filed yesterday, the Company remains subject to a Nasdaq Panel Monitor through November 22, 2024).
👍️0
TimeFades TimeFades 7 months ago
After hours loading opps took her down and rinsing . Wouldn’t be suprised to see new highs tmrw
👍️0
Whalatane Whalatane 7 months ago
This Co ( Mayo Clinic spin off ? ) appears to have first mover advantage .
https://anumana.ai
Kiwi
👍️0
Whalatane Whalatane 7 months ago
In late September 2023, the FDA cleared an algorithm for low ejection fraction (less than 40%) under the 510(k)-pathway using the new product code. Accordingly, we now believe it is probable that we could submit the MyoVista algorithm for clearance under the 510(k) pathway. The 510(k) pathway is more common than De Novo and, on average, has a much quicker decision process than De Novo by the FDA.
We have formally filed the request with the FDA and expect a response in late Q4 2023.

Likely to be make or break for this Co
JMO
Kiwi
👍️0
Whalatane Whalatane 7 months ago
Heart Test Laboratories 13G Filing Shows ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ("ISMMS") EIN 13-6171197 Reported 9.9% Stake In Co As Of November 16, 2023

Kiwi
👍️0
TimeFades TimeFades 7 months ago
Heading to 30s soon whales soaking
👍️0

Your Recent History

Delayed Upgrade Clock